Abstract:The title compound, C14H14BrNO4, contains a tricyclic ring system including three contiguous stereocenters all of which exhibit an R configuration. The cyclo-hexa-none ring adopts a chair conformation. The central oxane ring assumes a strained envelope conformation, with five of the ring atoms being nearly coplanar with the bromo-phenyl group and with the C atom adjacent to the O atom and fused with the cyclo-hexa-none ring as the flap. In the crystal, mol-ecules are linked into a three-dimensional network by C-H⋯O inter-actions.

1,4-Di-bromo-2,5-di-p-toluoyl-benzene.

4-Bromo-n-(3,4,5-trimethoxyphenyl)benzamide

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

2,2′-Diamino-4,4′-bi-1,3-thiazol-3,3′-diium Bis(2,2′-Diamino-4,4′-bi-1,3-thiazol-3-ium) Tetrakis(2-Nitrobenzoate)

(S)-2-[(s,z)-3-bromo-1-nitro-4-phenylbut-3-en-2-yl]cyclohexanone

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

1,4-Dibromo-2,5-dimeth-oxy-benzene.

(E)-4-chloro-benzyl 3-(3-Nitro-benzyl-idene)dithio-carbazate.

2-Bromo-5-iodo-1,3-dimethylbenzene

1,4-Bis(1h-benzotriazol-1-ylmethyl)benzene Tetrahydrate

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

Crystal Structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2h)-one, C23H25BrO6

5-Bromo-2-iodo-1,3-dimethyl-benzene.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(E)-1-(4-chlorophenyl)-3-(4-methoxyphenyl)-prop-2-en-1-one

2-Bromo-1-mesitylethanone.

Ethyl (2s,4r)-4-(4-Bromophenyl)-2-Hydroxy-5,10-Dioxo-3,4,5,10-Tetrahydro-2h-Be Nzo[G]Chromene-2-Carboxylate

(E)-3-(4-Hydroxyphenyl)-1-(4-methoxy-phenyl)prop-2-en-1-one

1,1&#8242;-Bicyclohexyl-1,1&#8242;-diyl 1,1&#8242;-biphenyl-2,2&#8242;-dicarboxylate

(E)-Benzyl 3-(3-Nitrobenzylidene)dithiocarbazate

2,5-Dibromoterephthalic Acid Dihydrate